Long-Term Outcomes of Pegcetacoplan for GA Show Promise
SEATTLE, Washington — Treatment with pegcetacoplan (Syfovre, Apellis Pharmaceuticals) produced clinically meaningful reductions in the growth of geographic atrophy (GA)
Read moreSEATTLE, Washington — Treatment with pegcetacoplan (Syfovre, Apellis Pharmaceuticals) produced clinically meaningful reductions in the growth of geographic atrophy (GA)
Read moreA large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect.
Read moreThe popular but expensive weight-loss drug, semaglutide (Wegovy), significantly reduced major adverse cardiovascular events (MACE) by 20% when given to
Read moreSource: Read Full Article
Read morePOTS or “postural orthostatic tachycardia syndrome” is a poorly recognized condition we’ve been hearing more about recently. When people stand
Read moreHunt for mystery ‘contaminated food’ behind killer E. coli outbreak striking kids: Health chiefs admit they have no idea what’s
Read moreBlack men twice as likely to be diagnosed with prostate cancer While changes in urinary patterns could be indicative of
Read moreSource: Read Full Article
Read moreHealth behaviors significantly changed throughout the coronavirus disease 2019 (COVID-19) pandemic. While many studies have assessed the impacts of health
Read moreReviewers’ Notes Lawrence Pfeffer, PhD, Professor in the Department of Pathology at the University of Tennessee Health Science Center, recently
Read more